Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4).

Marion J FokkertPeter van DijkMireille EdensEglantine BarentsJeanine MollemaRobbert SlingerlandReinold GansHenk Bilo

Published in: BMJ open diabetes research & care (2019)

Real world data demonstrate that use of FSL-FGM results in improved well-being and decreased disease burden, as well as improvement of glycemic control.

Keyphrases

glycemic control
type diabetes
blood glucose
risk factors
weight loss
insulin resistance
metabolic syndrome